Purpose-led, Performance-driven

DSM is a global science-based company operating in the fields of Nutrition, Health and Bioscience. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.

At a glance

Key facts and figures about DSM, our broad, global nutrition business and focused, high-quality, specialty materials portfolio and our people, planet & profit performance.

Results center

Annual Results published on 15 February confirm DSM delivered a solid financial performance in 2021 and achieved key milestones in its strategic journey.
 

Share center

In 2019 DSM celebrated the 30th anniversary of its privatisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Headlines (continuing operations) 2021

€9,204m

Net sales

€8,106m in 2020

€1,814m

Adjusted EBITDA

€1,534m in 2020

19.7%

Adjusted EBITDA margin

18.9% in 2020

Nutrition

Our Nutrition cluster comprises DSM Nutritional Products, DSM Food Specialties and DSM Hydrocolloids. This cluster provides solutions for animal precision nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, personalized nutrition and personal care.

We are active at all stages of the associated value chains, producing pure active ingredients, incorporating them into sophisticated forms and providing tailored premixes, forward solutions and branded consumer products. Our unique portfolio of products and services is global and highly diversified, serving customers and other stakeholders locally across an extensive range of end-markets worldwide.

€7,031m

Net sales

€6,365 in 2020. >80% of group net sales

€1,447m

Adjusted EBITDA

€1,338 in 2020

20.6%

Adjusted EBITDA margin

21.0% in 2020 & an ambition of >20%

€3,502m

Animal nutrition

Sales: ↑ (2020: €3,025)
Organic Growth: ↑10%
Volume Growth: ↑10%
Price Growth: 0%

>55

Animal nutrition premix facilities

& 15 human nutrition premix facilities

€2,207m

Human nutrition

Sales: ↑ (2020: €2,143)
Organic Growth: ↑5%
Volume Growth: ↑4%
Price Growth: ↑1%

>€1bn

of sales

came from immunity-optimizing ingredients in 2021

€716m

Food Specialties

Sales: ↑ (2019: €572)
Sales: ↑10%
Organic Growth: ↑9%

70%

reduction in land use

with EVERSWEET™ stevia sweetener compared to bio-converted Reb M

€484m

Personal Care

Sales: ↑ (2019: €425)
Sales: ↑20%
Organic Growth: ↑21%

>70%

of our skin care portfolio

is > 90% natural in origin

Materials

Our Materials cluster comprises DSM Engineering Materials and DSM Protective Materials. The cluster comprises a high-quality portfolio of specialty materials for global end-markets including electrical components and electronics, automotive, food packaging, medical, personal protection, commercial marine, and apparel. Through our advanced and sustainable solutions, we are meeting demand for safer materials, greater efficiency and improved environmental performance.

€1,935m

Net sales

€1,518 in 2020

€435m

Adjusted EBITDA

€272 in 2020

22.5%

Adjusted EBITDA margin

17.9% in 2020

28%

Organic sales development

-12% in 2020

€1,600m

Engineering Materials

Sales: ↑ (2020: €1,217)
Sales: ↑31%
Volume Growth: ↓6%

100%

Engineering Materials plants in Europe

run fully on purchases electricity from renewable resources

100%

of Engineering Materials portfolio

to contain alternatives with >25% recycled and/or bio-based content by 2030

€335m

Protective Materials

Sales: ↓ (2020: €301)
Sales: ↑11%
Volume Growth: ↓9%

2 kt

CO2eq emissions

were avoided in 2021 by using bio-based feedstock for Dyneema®

Latest financial & regulatory news

  • Final dividend 2021 Royal DSM

    Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders.

    10 May 2022

  • DSM - repurchase of shares (2-6 May 2022)

    Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08.

    10 May 2022

Read more

  • At a glance

    At a glance

    Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.

  • Financial results & presentations

    Financial results & presentations

    Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.